#Recruitment challenges, regulatory challenges, patient safety, and more... Check out this The Clinical Trial Vanguard interview where Curavit's CEO, Joel Morse, is joined by Digital Therapeutics Alliance's CEO, Andy Molnar, to highlight the key issues in expanding access to #digitaltherapeutics and discuss how #decentralizedclinicaltrials can help lighten the burden. #dtx #dct #clinicalresearch https://lnkd.in/esvU3Rc3
